Search - tctmd.com

Displaying 21 - 40 of 219

Sort: Relevancy | Date

Bivalirudin Plus a High-dose Infusion Versus Heparin Monotherapy in Patients with STEMI Undergoing Primary PCI: The BRIGHT-4 Trial

Presentation AHA 2022

Bivalirudin Plus a High-dose Infusion Versus Heparin Monotherapy in Patients with STEMI Undergoing Primary PCI: The BRIGHT-4 Trial

Presenter: Gregg W. Stone

November 07, 2022

BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI

News Conference News AHA 2022

BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI

November 06, 2022

RIVARAD: Rivaroxaban a Possible Solution to Radial Artery Occlusion

News Conference News TCT 2022

RIVARAD: Rivaroxaban a Possible Solution to Radial Artery Occlusion

September 21, 2022

Presentation TCT 2022

TCT 590: Comparison of Different Doses of Heparin on Prevention of Radial Artery Occlusion After Diagnostic Transradial Catheterization

Presenter: Jose Costa Jr

September 19, 2022

Less Death, Major Bleeding With Transradial Access: Meta-analysis

News Conference News ESC 2022

Less Death, Major Bleeding With Transradial Access: Meta-analysis

Michael O'Riordan

August 29, 2022

Distal Radial Access Doesn’t Lower Risk of Occlusion: DISCO RADIAL

News Conference News EuroPCR 2022

Distal Radial Access Doesn’t Lower Risk of Occlusion: DISCO RADIAL

Michael O'Riordan

May 19, 2022

Potassium Ferrate Patch Speeds Hemostasis, Discharge After Radial PCI

News Conference News EuroPCR 2022

Potassium Ferrate Patch Speeds Hemostasis, Discharge After Radial PCI

May 17, 2022

Nitroglycerin Given Early or Late Fails to Prevent Radial Artery Occlusion: PATENS

News Conference News ACC 2022

Nitroglycerin Given Early or Late Fails to Prevent Radial Artery Occlusion: PATENS

Michael O'Riordan

March 25, 2022

REMAP-CAP: Mixed Results for Antiplatelets in Critical COVID-19

News Daily News

REMAP-CAP: Mixed Results for Antiplatelets in Critical COVID-19

March 22, 2022

Still No Edge for Bivalirudin in VALIDATE-SWEDEHEART’s STEMI Patients

News Daily News

Still No Edge for Bivalirudin in VALIDATE-SWEDEHEART’s STEMI Patients

December 22, 2021

No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials

News Conference News AHA 2021

No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials

November 15, 2021

Rare Clotting Complication Seen After mRNA Vaccine: Case Report

News Daily News

Rare Clotting Complication Seen After mRNA Vaccine: Case Report

June 28, 2021

Subcutaneous GP IIb/IIIa Inhibitor in STEMI Is Fast, Potent in Early Study

News Conference News EuroPCR 2021

Subcutaneous GP IIb/IIIa Inhibitor in STEMI Is Fast, Potent in Early Study

May 18, 2021

Compression Times Cut With Adjunctive Hemostatic Patch After Transradial Procedures

News Conference News SCAI 2021

Compression Times Cut With Adjunctive Hemostatic Patch After Transradial Procedures

Michael O'Riordan

May 03, 2021

Lean Antithrombotic Regimen Recommended After TAVI

News Daily News

Lean Antithrombotic Regimen Recommended After TAVI

April 12, 2021

Papers Confirm Rare Thrombocytopenia Link to AstraZeneca Vaccine

News Daily News

Papers Confirm Rare Thrombocytopenia Link to AstraZeneca Vaccine

April 09, 2021

The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive

News Features

The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive

February 08, 2021

Fall in Hemoglobin Without Overt Bleeding May Be Prognostic in ACS

News Daily News

Fall in Hemoglobin Without Overt Bleeding May Be Prognostic in ACS

January 26, 2021

Web-Like Structures in COVID-19 STEMI Clots May Offer New Drug Target

News Daily News

Web-Like Structures in COVID-19 STEMI Clots May Offer New Drug Target

January 04, 2021

Microclots Seen on OCT and Autopsy Can Inform COVID-19 Diagnostics, Care

News Conference News TCT 2020

Microclots Seen on OCT and Autopsy Can Inform COVID-19 Diagnostics, Care

October 26, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.